Pharma Roundup: Lilly and ImClone Sued, Buyout Spree Still Predicted, and More

Pension fund sues over Lilly/ImClone deal -- The State-Boston Retirement System of Massachusetts, along with several other ImClone shareholders, claims in the suit that the $70 Lilly paid per share was too low. [Source: Pharmalot]

Pharma buyouts of biotech close? -- Predictions are flying that pharma companies are about to embark on a buying spree of biotech firms, fueled by credit woes for biotech funding. The Philadelphia Inquirer joins the speculation. [Source: FiercePharma]

On a similar note... -- In London, the "Genomics and Society: Reinventing Life?" conference has warned the world that biotech's funding woes mean new medicines are less likely. [Source: Medical News Today]